Methods For The Identification, Evaluation And Treatment Of Patients Having Multiple Myeloma

Patent No. EP3370729 (titled "Methods For The Identification, Evaluation And Treatment Of Patients Having Multiple Myeloma") was filed by Celgene on Nov 4, 2016. The application was issued on Sep 27, 2023.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
TEVA PHARMACEUTICALSJun 25, 2024KRAUS & LEDERER PARTGMBB

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3370729

CELGENE
Application Number
EP16810119A
Filing Date
Nov 4, 2016
Status
Revoked
Nov 8, 2024
Publication Date
Sep 27, 2023